Marine Bio (MBII) Reports In-Line Q2 EPS, Enters Microbial Product Development Pact with Albaugh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Marrone Bio Innovations Reports Second Quarter 2016 Results
August 9, 2016 4:05 PM EDTThird Consecutive Quarter of Strong Year-over-Year Growth
Second Quarter Revenues up 50%; Second Quarter Product Shipments up 68%
Second Quarter Net Cash and Equivalents and Restricted Cash Usage of $4.1 million
Total Cash and Equivalents and Restricted Cash of $24.2 million
DAVIS, Calif.--(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management and plant health products, today announced results for the second quarter ended June 30, 2016.
Second Quarter Results
... More
Albaugh and Marrone Bio Innovations Sign Exclusive Seed Treatment Agreement for a Microbial Biopesticide Product
August 9, 2016 8:31 AM EDTDAVIS, Calif.--(BUSINESS WIRE)-- Albaugh, LLC, a leading provider of crop protection products and seed treatment technology and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today the companies have signed an exclusive agreement to develop and market one of MBIs microbial products, a proprietary microbial biopesticide with insecticidal and nematicidal properties, for seed treatment applications.
Dr. Pam Marrone, Founder and Chief Executive Officer of Marrone Bio Innovations, commented, We are pleased to add Albaugh to our... More
